GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Entourage Health Corp (OTCPK:ETRGF) » Definitions » EV-to-EBITDA

Entourage Health (Entourage Health) EV-to-EBITDA : -1.59 (As of May. 12, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Entourage Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Entourage Health's enterprise value is $110.04 Mil. Entourage Health's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-69.24 Mil. Therefore, Entourage Health's EV-to-EBITDA for today is -1.59.

The historical rank and industry rank for Entourage Health's EV-to-EBITDA or its related term are showing as below:

ETRGF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1908.32   Med: -2.1   Max: 29.32
Current: -1.6

During the past 9 years, the highest EV-to-EBITDA of Entourage Health was 29.32. The lowest was -1908.32. And the median was -2.10.

ETRGF's EV-to-EBITDA is ranked worse than
100% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.76 vs ETRGF: -1.60

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-12), Entourage Health's stock price is $0.00945. Entourage Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.273. Therefore, Entourage Health's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Entourage Health EV-to-EBITDA Historical Data

The historical data trend for Entourage Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entourage Health EV-to-EBITDA Chart

Entourage Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -352.29 -22.50 -1.43 -1.76 -1.31

Entourage Health Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.24 -1.31 -1.44 -1.41 -1.62

Competitive Comparison of Entourage Health's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Entourage Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entourage Health's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Entourage Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Entourage Health's EV-to-EBITDA falls into.



Entourage Health EV-to-EBITDA Calculation

Entourage Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=110.040/-69.238
=-1.59

Entourage Health's current Enterprise Value is $110.04 Mil.
Entourage Health's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-69.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entourage Health  (OTCPK:ETRGF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Entourage Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.00945/-0.273
=At Loss

Entourage Health's share price for today is $0.00945.
Entourage Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.273.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Entourage Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Entourage Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Entourage Health (Entourage Health) Business Description

Traded in Other Exchanges
Address
250 Elm Street, Aylmer, ON, CAN, N5H 2M8
Entourage Health Corp is a licence holder producing and distributing cannabis products for both the medical and adult-use markets. It owns and operates greenhouse, outdoor, and processing facility located in Strathroy as well as a fully licensed Aylmer processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, it has expanded its multi-channeled distribution. The company operates in one segment, the production and sale of cannabis in Canada.